Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Total Non-Current Liabilities came in at $1.6 billion in Q2 2026, up 16.06% YoY from $1.3 billion in Q2 2025, and up 6.29% on a QoQ basis from $1.5 billion in Q1 2026.
Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Total Non-Current Liabilities data on file, last reported at $1.6 billion in Q2 2026.
- Quarterly Total Non-Current Liabilities rose 16.06% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 16.06% YoY) and the FY2025 annual result came in at $1.5 billion, up 18.35% from the prior year.
- Total Non-Current Liabilities rose to $1.6 billion in Q2 2026, from $1.5 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.6 billion in Q2 2026 to a low of $722.1 million in Q1 2022.
- A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 68.68% — and 2023, when it fell 2.17%.
- Tracing MEDP's Total Non-Current Liabilities over 5 years: stood at $943.4 million in 2022, then increased by 13.38% to $1.1 billion in 2023, then rose by 15.23% to $1.2 billion in 2024, then climbed by 18.35% to $1.5 billion in 2025, then climbed by 7.2% to $1.6 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $1.6 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.88 Bn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 1.56 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.56 Bn |
| Mar 31, 2026 | 1.47 Bn |
| Dec 31, 2025 | 1.46 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.35 Bn |
| Mar 31, 2025 | 1.25 Bn |
| Dec 31, 2024 | 1.23 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.13 Bn |
| Mar 31, 2024 | 1.10 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 992.69 Mn |
| Jun 30, 2023 | 992.93 Mn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 943.41 Mn |
| Sep 30, 2022 | 960.98 Mn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 722.11 Mn |
| Dec 31, 2021 | 689.26 Mn |
| Sep 30, 2021 | 663.00 Mn |